Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Delivery: Parenteral Route

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comprehensive Performance Testing and External Validation of an AI Algorithm to Detect and Segment Brain Metastases.

Neuro-oncology·2026

Same author

Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma.

Redox biology·2026

Same author

Dynamic Brain [F18]-Fluoroestradiol (FES) PET Protocol Optimization for Improved Detection of Breast Cancer Brain Metastases.

AJNR. American journal of neuroradiology·2026

Same author

[68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response Biomarker.

AJNR. American journal of neuroradiology·2026

Same author

Characterization of a pathogenic subpopulation of human glioma associated macrophages linked to glioma progression.

Cancer cell·2026

Same author

Long-term outcomes of active surveillance after DOTATATE PET/MRI-confirmed gross total resection in WHO grade 2 meningioma.

Neuro-oncology advances·2026

Search research articles

Related Experiment Video

Updated: Sep 23, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Brachytherapy for central nervous system tumors.

Evan D Bander¹, Jonathan P S Knisely², Theodore H Schwartz^3,4

¹Department of Neurosurgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.

Journal of Neuro-Oncology

|May 13, 2022

Summary

This summary is machine-generated.

Brachytherapy, a localized radiation treatment for central nervous system (CNS) tumors, offers advantages but requires standardized data. This review highlights evidence and future directions for CNS tumor brachytherapy.

Keywords:

Brachytherapy Brain Metastases Cesium Glioma Iodine Meningioma Radiation

More Related Videos

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

Stereotactic Radiosurgery for Gynecologic Cancer

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Related Experiment Videos

Last Updated: Sep 23, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

Stereotactic Radiosurgery for Gynecologic Cancer

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Area of Science:

Oncology
Radiation Oncology
Neurosurgery

Background:

Radiation therapy is a primary treatment for central nervous system (CNS) tumors.
Brachytherapy, involving localized radiation sources, presents unique benefits for CNS tumor treatment.
Current data on brachytherapy efficacy is limited by inconsistencies in sources, techniques, doses, and trial designs.

Purpose of the Study:

To identify consistent themes in brachytherapy for CNS tumors.
To review high-level evidence and potential indications for its use.
To highlight future research directions for CNS tumor brachytherapy.

Main Methods:

Literature review focusing on brachytherapy in CNS tumors.
Analysis of existing data to identify trends and evidence.
Synthesis of information on indications, complications, and collaborations.

Main Results:

Variability in brachytherapy approaches complicates data interpretation.
Despite limitations, specific settings may benefit from brachytherapy.
Further research is needed to standardize techniques and optimize outcomes.

Conclusions:

Brachytherapy holds promise for CNS tumors but requires more consistent evidence.
Understanding tumor biology and refining techniques are crucial for its resurgence.
Industry-academic collaborations can drive advancements in CNS tumor brachytherapy.